More Argent Biopharma Ltd news
Argent Biopharma LtdASX: RGT

Agreement with SipNose takes MXC into Global Epilepsy Market

Mar 2, 2016 at 10:42 PM EST · Issued by Argent Biopharma Ltd

Filed with ASX · Mar 2, 2016 at 10:42 PM EST

On 6ix: 6ix.com/news/agreement-with-sipnose-takes-mxc-into-global-epilepsy-market

Argent Biopharma Limited has released a press release.

View Attachment

6ix hasn’t read this filing yet.

Argent Biopharma Ltd on 6ix

Earlier from Argent Biopharma

  • Legalisation of Medical Cannabis Fast Tracks Aus OpportunityFeb 24, 2016
  • Reinstatement to Official Quotation (23/02/2016)Feb 19, 2016
  • Suspension from official quotationFeb 11, 2016
  • MGC to Collaborate with Leading University of Sydney FacultyFeb 10, 2016

Later from Argent Biopharma

  • MXC Secures First Cosmetics Sales AgreementMar 24, 2016
  • MXC Publishes First Australian Med Cannabis White PaperMar 28, 2016
  • Drilling started at Lingokoto gold project, SenegalMar 30, 2016
  • MXC to Enter Australian Medicinal Cannabis MarketApr 4, 2016
  • Response to ASX Price QueryApr 18, 2016
All Argent Biopharma news releases↗

Follow Argent Biopharma into a list and get an email when it puts out news.

Follow Argent Biopharma
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer